Immunotherapy | Tumor

CURE’s immunotherapy page features the latest cancer news and updates on immunotherapy Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in immunotherapy.

Despite Advances, Education Tools Still Needed for Immunotherapy Treatment

March 5th 2018, 9:27pm

Article

Recently, the Cancer Support Community (CSC) conducted a survey to better grasp the challenges that patients, caregivers and clinical staff members face regarding immunotherapy. The goal is to ultimately use that information to craft an empowerment program that will improve the patient experience.

Future of Immunotherapy in Liver Cancer

February 26th 2018, 8:21pm

Video

What to Expect With Immunotherapy in Liver Cancer

February 26th 2018, 8:21pm

Video

How Immunotherapy Works in Liver Cancer

February 26th 2018, 8:21pm

Video

Treating Liver Cancer That Has Spread

February 26th 2018, 8:21pm

Video

Treatment Options for Liver Cancer

February 26th 2018, 8:21pm

Video

Guidelines Equip Patients to Understand Immunotherapy Side Effects

February 20th 2018, 8:11pm

Article

To help educate patients and enable health care teams to effectively manage these side effects, the National Comprehensive Cancer Network (NCCN) and the American Society of Clinical Oncology (ASCO) issued new guidelines on understanding and managing immunotherapy-related toxicities.

Efficacy Offsets High Costs for Immunotherapy in US, But Not Overseas

February 14th 2018, 8:41pm

Article

Researchers from Israel, the United Kingdom (UK) and Canada sought to determine the cost-effectiveness of Keytruda for the second-line treatment of patients with advanced bladder cancer. Drug costs were compared between the US, UK, Canada and Australia.

Managing Toxicity Amidst Immunotherapy Expansion in Bladder Cancer Is Critical

February 5th 2018, 7:59pm

Article

Now that a number of immunotherapy agents have been approved in the bladder cancer space, identifying and managing the toxicities that may come along with them is critical.

Adding Tecentriq to Chemo Regimen Improves Lung Cancer Outcomes

January 31st 2018, 12:48am

Article

Not all patients with non-small cell lung cancer (NSCLC) respond to immunotherapy, so researchers are exploring the use of combination regimens, including immune checkpoint inhibitors and chemotherapy, to improve outcomes in these patients.